Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis.

作者信息

Sánchez-Herrero Estela, Serna-Blasco Roberto, Robado de Lope Lucia, González-Rumayor Víctor, Romero Atocha, Provencio Mariano

机构信息

Liquid Biopsy Laboratory. Biomedical Sciences Research Institute Puerta de Hierro-Majadahonda, Majadahonda, Spain.

+D Department, Atrys Health, Barcelona, Spain.

出版信息

Front Oncol. 2022 Jul 20;12:943253. doi: 10.3389/fonc.2022.943253. eCollection 2022.

Abstract

Cancer cells release nucleic acids, freely or associated with other structures such as vesicles into body fluids, including blood. Among these nucleic acids, circulating tumor DNA (ctDNA) has emerged as a minimally invasive biomarker for tumor molecular profiling. However, certain biological characteristics of ctDNA are still unknown. Here, we provide an overview of the current knowledge about ctDNA biological features, including size and structure as well as the mechanisms of ctDNA shedding and clearance, and the physio-pathological factors that determine ctDNA levels. A better understanding of ctDNA biology is essential for the development of new methods that enable the analysis of ctDNA.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/367b/9350013/acb4ba76c797/fonc-12-943253-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索